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Insulin and EGF cause identical stimulation (-407;) of fatty acid synthesis in hepatocytes isolated from 
rats which have been starved and then refed a low-fat diet. In both cases this stimulation is associated with 
increased phosphorylation of ATP-citrate lyase and of a specific site on acetyl-CoA carboxylase. However, 
the altered phosphorylation of acetyl-CoA cdrboxylase is not associated with a change in kinetic parameters 
which is detectable in the purified enzyme. Whatever the mechanism involved, stimulation of fatty acid syn- 
thesis by growth factors may have a role in providing new phospholipid for growth of membranes. 
Insulin Epidermal growth factor ATP-citrate lyase 
1. INTRODUCTION 
Fatty acid synthesis is acutely regulated by 
several hormones. Glucagon in hepatocytes [1,2], 
and adrenaline [3] and glucagon [4] in adipocytes, 
cause inhibition of fatty acid synthesis, and lead to 
increased phosphorylation of the two lipogenic en- 
zymes, ATP-citrate lyase and acetyl-CoA carbox- 
ylase [5--S]. Peptide mapping data suggest that 
these phosphorylations are catalyzed by cyclic 
AMP-dependent protein kinase [8-l 11, and the 
phosphorylation of acetyl-CoA carboxylase, but 
not ATP-citrate lyase, causes inactivation of the 
enzyme, sufficient to account for the inhibition of 
fatty acid synthesis by these hormones [12-141. 
Insulin stimulates fatty acid synthesis in both 
adipocytes and hepatocytes, and, contrary to ex- 
pectation, also leads to increased phosphorylation 
* To whom correspondence should be addressed 
Abbreviations: EGF, epidermal growth factor; IGF-1, 
insulin-like growth factor-l; HPLC, high-performance 
liquid chromatography; PDGF, platelet-derived growth 
factor 
Acetyl-CoA carbo.+ase Protein phosphorylation 
of both ATP-citrate lyase and acetyl-CoA carbox- 
ylase [2,15-181. In the case of ATP-citrate lyase 
the insulin-stimulated phosphorylation occurs at 
the same serine residue as that phosphorylated by 
cyclic AMP-dependent kinase [ 181, while for 
acetyl-CoA carboxylase the insulin-stimulated site 
and the cyclic AMP-dependent protein kinase site 
are distinct [16,17]. Current evidence suggests that 
insulin acts by increasing the activity of a soluble, 
Ca2+ and cyclic AMP-independent protein kinase 
]l91. 
The insulin receptor shares a common feature 
with receptors for certain growth factors (e.g., 
EGF, PDGF, IGF-1) in that it possesses ligand- 
dependent tyrosine kinase activity [20-231. Treat- 
ment of cultured cells with insulin or growth fac- 
tors such as EGF also brings about increased 
phosphorylation, on serine residues, of the same 
set of intracellular proteins, including ribosomal 
protein S6 [24], and an unidentified, heat-stable 
22-kDa polypeptide [25]. We therefore compared 
the effects of insulin and EGF on the rate of fatty 
acid synthesis and the phosphorylation of 
lipogenic enzymes in isolated hepatocytes. 
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2. MATERIALS AND METHODS 
Isolation of hepatocytes from rats which had 
been starved and then refed a low-fat diet, and 
measurement of fatty acid synthesis were as in 
[lo]. Purification of acetyl-CoA carboxylase from 
hepatocytes, and estimation of its kinetic 
parameters and specific radioactivity were as in 
[lOI. 32P-labelled acetyl-CoA carboxylase was 
digested with trypsin and analysed by reversed- 
phase HPLC as in [17] except that an on-line 
radioactive monitor (Reeve Analytical Ltd, 
Glasgow) connected to a Hewlett-Packard 85B 
microcomputer was used to detect and quantify 
radioactive peaks. Purification of acetyl-CoA car- 
boxylase from lactating rat mammary gland and its 
phosphorylation by casein kinase II was as in [14]. 
Casein kinase II was purified from rabbit skeletal 
muscle [26] and was a gift from J.R. Woodgett of 
this department. EGF purified from mouse sub- 
maxillary gland was a gift from Dr Peter Parker of 
the Imperial Cancer Research Fund, London. Por- 
cine insulin was from Novo Industries (Denmark). 
Sources of other materials are as in [10,14]. 
3. RESULTS 
As reported previously [2], insulin causes a 
3.1. Effects of insulin and EGF on fatty acid 
synthesis 
modest stimulation of fatty acid synthesis in 
isolated hepatocytes (table 1). Maximal effects are 
observed at > 10 nM insulin, with half-maximal ef- 
fects at 0.8 nm (not illustrated). We now report 
that EGF produces an almost identical effect to 
that of insulin (table 1). Maximal effects were 
observed at > 10 nM EGF (not shown). 
3.2. Effects of insulin and EGF on the 
phosphorylation of cytosolic proteins 
tide, identified as 
Isolated hepatocytes were preincubated with 
acetyl-CoA carboxylase [5, lo], 
[32P]phosphate for 60 min to achieve steady-state 
labelling of acetyl-CoA carboxylase and other pro- 
teins [10,27] and were then treated with or without 
insulin or EGF for 15 min. Fig.1 shows that 
phosphorylation of 116- and 46-kDa polypeptides 
was stimulated by both insulin and EGF, as found 
by others (unpublished data quoted in [28]). The 
116-kDa phosphopeptide is not observed in cells 
from fasted rats (not illustrated), comigrates with 
purified ATP-citrate lyase, and has been identified 
as this latter protein previously [29]. The effects of 
EGF on the phosphorylation of these two polypep- 
tides are smaller than those of insulin (fig.l), par- 
ticularly for the 46-kDa polypeptide, although 
maximally effective doses were used for each hor- 
mone/growth factor. The 240-kDa phosphopep- 
Table I 
Effects of insulin and EGF treatment of isolated hepatocytes on rates of fatty acid 
acetyl-CoA carboxylase purified from the cells 
synthesis and on the properties of 
Control Insulin EGF 
(1 mu/ml) (100 ng/ml) 
Pathway parameter 
Rate of fatty acid synthesis 
(relative to control) 1.0 1.37 f 0.04 (lS)b 1.36 f 0.05 (4)” 
Enzyme parameters 
Vmax @mol/min per mg) 
V,,, (relative to control) 
K, for citrate (mM) 
Specific radioactivity 
(relative to control) 
317 f 58 (5) 274 f 35 ( 5) 312 f 65 (3) 
1.0 0.90 f 0.07 ( 5) 0.90 5 0.07 (3) 
7.5 + 1.0 (5) 7.6 + 0.9 ( 5) 7.0 * 0.3 (3) 
1.0 0.99 -t 0.04 ( 9) 0.99 f 0.03 (6) 
Rates of fatty acid synthesis were measured using [3H]Hz0 [lo] between 5 and 35 min after hormone addition. Specific 
radioactivity of acetyl-CoA carboxylase was determined for enzyme isolated from “P-1abelled cells [lo]. Data are 
expressed as mean + SE of the mean for the number of cell incubations shown in brackets. Data shown with asterisks 
are significantly different from controls by the paired t-test: a p < 0.01; b p < 0.001 
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Fig.1. Analysis of radioactivity in proteins in a 100000 x 
g supernatant fraction prepared from 32P-labelled 
hepatocytes. Proteins were separated in a 7% 
po~yacryIamide gel in the presence of SDS and were 
detected by autoradiography as in [lo]. The molecular 
masses of major phosphoproteins (shown at left) were 
estimated by reference to the mobility of marker 
proteins as in [IO]. I, insulin (0.8 nM); C, control; EGF, 
EGF (16 nMf. 
showed no apparent change in total 32P-labelling in 
response to insulin or EGF (fig.1). 
3.3. Effects of ins~iin and EGF on the properties 
of purified acetyl-CoA car~o~yia~e 
isolated hepatocytes were preincubated with 
[32P]phosphate for 60 min and then acetyl-CoA 
carboxylase was purified from control, insulin- 
and EGF-treated cells by avidin-Sepharose 
chromatography. There were no significant 
changes in the specific radioactivity or the kinetic 
parameters of the isolated enzyme (table 1). 
However, when tryptic digests were analysed by 
reversed-phase HPLC, both insulin (fig.2, table 2) 
and EGF (table 2) caused increases in the 32P- 
labelling of a specific tryptic peptide (peptide 4). 
This peptide was distinct from that containing the 
major site of phosphorylation for cyclic AMP- 
dependent protein kinase (which corresponded to 
peptide 1; not illustrated), but comigrated with the 
peptide containing the major site of phosphoryla- 
tion for casein kinase II, both on reversed-phase 
15 
60 
10 
LO 
5 
20 
Retention time (mln) 
Fig.2. Analysis of radioactivity in tryptic peptides of 
purified acetyl-CoA carboxylase. C, enzyme purified 
from control 32P-labelled cells; I, enzyme purified from 
insulin-treated (0.8 nM) cells; CK2, enzyme purified 
from mammary gland and phosphorylated in vitro with 
[Y-~‘P]ATP and casein kinase II. 
HPLC (fig.2) and thin-layer isoelectric focussing. 
The 32P-labelling of peptide 1 was unchanged by 
insulin or EGF; labelling of peptide 3 did not 
change significantly with insulin but decreased 
slightly with EGF (table 2). Peptide 2 was not 
observed consistently and appears to be related to 
peptide 4, since on some occasions digestion of 
acetyl-CoA carboxylase phosphorylated by casein 
kinase II gave a peptide with the same retention 
time as peptide 2 (not illustrated). Peptides 2 and 
4 were therefore counted together for the quan- 
tification in table 2. 
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Table 2 
Effects of insulin and EGF treatment on the 32P- 
~abelling of individual tryptic peptides of acetyl-CoA 
carboxylase 
Control Insulin EGF 
(1 mu/ml) (100 ng/ml) 
Peak 1 
Peak 3 
Peak 4 
1.0 0.97 t 0.03 (4) I .OO -+ 0.06 (4) 
1.0 0.99 -+ 0.09 (4) 0.85 -+ 0.02 (4)b 
(+2) 1.0 1.39 &I 0.03 (4)’ 1.92 rt 0.22 (4)” 
Results are expressed relative to control incubations. 
Peaks were quantified after separations imilar to those 
in fig.2, as described in section 2. Peaks 2 and 4 have 
been counted together as discussed in section 3. Data 
marked are significantly different from controls by the 
paired t-test: a p < 0.01; b p < 0.01; ’ p < 0.002 
4. DISCUSSION 
These results emphasize the similarity between 
the acute effects of insulin and those of growth 
factors such as EGF. Both extracellular messengers 
stimulate autophosphorylation of their respective 
cell surface receptors on tyrosine residues 1281; 
both cause increased phosphorylation on serine 
residues of the same set of intracellular proteins 
[24,25] to which may now be added ATP-citrate 
lyase and acetyl-CoA carboxylase. We also now 
report that insulin and EGF have identica1 effects 
on the rate of fatty acid synthesis in isolated 
hepatocytes. Despite this correlation between in- 
creased phosphorylation of lipogenic enzymes and 
increased fatty acid synthesis, it is still not clear 
that the two events are causaI1y reIated. Insulin 
treatment of adipocytes [19] or hepatocytes [2] 
leads to increases in acetyl-CoA carboxylase activi- 
ty measurable in crude extracts of the cells. 
However, while the effect of insulin on 
phosphorylation of acetyl-CoA carboxylase in 
adipocytes urvives purification of the enzyme, the 
effect on enzyme activity does not 1171. Our pre- 
sent results show that this dissociation of the ef- 
fects on activity and phosphorylation also holds 
for effects of both insulin and EGF in hepatocytes. 
These findings imply either that the change in 
phosphorylation is unrelated to enzyme activation, 
or that a factor which is removed during enzyme 
purification is necessary for the effect of 
phosphorylation at the insulin- and EGF-sensitive 
site to be observed. 
The correspondence between the insulin- and 
EGF-sensitive peptide on acetyl-CoA carboxylase 
and a peptide containing the major site of 
phosphorylation by casein kinase II is in agreement 
with results obtained previously on insulin treat- 
ment of adipocytes [17]. Phosphorylation within 
this peptide by casein kinase II has no effect on the 
activity of purified acetyl-CoA carboxylase 
[14,30]. However, although comigration in two 
different analytical systems suggests trongly that 
the peptides phosphoryiated by casein kinase II 
and in response to insuIin/EGF are identical, it re- 
mains to be demonstrated whether the same 
residue within this peptide is phosphorylated in 
each case. Witters et al. [17] also reported that ca- 
sein kinase I phosphorylates a peptide similar in 
retention time to the insulin-sensitive peptide, and 
Cobb and Rosen I311 have reported that a protein 
kinase phosphorylating ribosomal protein 56, and 
which is enhanced in activity following insulin 
treatment of 3T3-Ll cells, resembles casein kinase 
I. We found that casein kinase I did phosphorylate 
site(s) on acetyl-CoA carboxylase in a peptide 
similar in retention time to the insulin- and EGF- 
sensitive peptide, but that it phosphorylated 
numerous other sites also, and hence lacks the 
specificity to account for the effects of insulin and 
EGF (not shown). 
The precise physiologica role of EGF is still far 
from clear, so the significance of the stimulation of 
fatty acid synthesis by EGF is currently difficult to 
evaluate. Of the three identified intracellular pro- 
tein phosphorylations which are stimulated by in- 
sulin and growth factors, two (ATP-citrate lyase 
and acetyl-CoA carboxylase) are associated with 
stimulation of fatty acid synthesis and one 
(ribosomal protein S6) with activation of protein 
synthesis. It is not unreasonable that rapidly grow- 
ing and/or dividing cells would require rapid fatty 
acid synthesis for the supply of membrane lipid, 
just as they will require new protein. Although the 
activation of fatty acid synthesis may be a rather 
peripheral event in the overall effect of growth fac- 
tors on cell growth and division, it does represent 
a simple system with which to attempt elucidation 
of the mechanism of growth factor action. In par- 
ticular, it may prove useful in the identification of 
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protein (serineithreonine) kinases which are ac- 
tivated by growth factors. Further studies are be- 
ing conducted along this approach. 
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